— Know what they know.
Not Investment Advice
Also trades as: DBV.PA (PAR) · $vol 2M

DBVT NASDAQ

DBV Technologies S.A.
1W: -8.7% 1M: -22.5% 3M: -32.4% YTD: -44.6% 1Y: +4.8% 3Y: -18.9% 5Y: -78.9%
$10.55
-0.66 (-5.89%)
 
Weekly Expected Move ±8.3%
$9 $10 $11 $11 $12
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 26 · $252.4M mcap · 15M float · 2.17% daily turnover · Short 54% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$18M -159.4% ▼
Operating Income
-$153M -27.1% ▼
Net Income
-$147M -29.6% ▼
EPS (Diluted)
$-5.30 +10.2% ▲
EBITDA
-$135M -22.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$6M$5M$16M$0$0
YoY Growth-49.4%-15.9%+227.7%-100.0%+0.0%
Cost of Revenue$9M$20M$0$7M$18M
Gross Profit-$4M-$15M$16M-$7M-$18M
Gross Margin-62.5%-322.9%100.0%——
R&D Expenses$70M$76M$60M$90M$23M
SG&A Expenses$24M$18M$32M$24M$17M
Operating Expenses$94M$101M$92M$114M$40M
Operating Income-$99M-$97M-$76M-$121M-$153M
Operating Margin-1727.6%-2013.1%-486.0%——
Interest Expense$690K$427K$0$0$0
Income Before Tax-$98M-$96M-$73M-$118M-$153M
Tax Expense-$381K$70K$7K-$4M-$5M
Net Income-$98M-$96M-$73M-$114M-$147M
Net Margin-1713.5%-2006.2%-462.4%——
EPS (Diluted)$-8.90$-6.20$-3.80$-5.90$-5.30
EBITDA-$91M-$77M-$63M-$111M-$135M
Shares Outstanding11M15M19M19M28M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms